Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase 4: Therapeutic dose (Weeks 13-16) Dose: 8 mg or 9 mg once weekly What to expect: Strong appetite suppression Significant ongoing weight loss Possible temporary GI flare during escalation Many reach 10-15% weight loss by this phase Tips: This is where most people stabilize 8 mg may be sufficient for manyhigher isn't always better Continue lifestyle optimization Regular check-ins with healthcare provider Phase 5: Maximum dose (Week 17+) Dose: 12 mg once weekly (if tolerated and needed) What to expect: Maximum therapeutic effect Continued weight loss (averaging 20%+ by 48 weeks in trials) GI side effects may be manageable or may persist Some achieve 25-30%+ weight loss Tips: Not everyone needs to reach 12 mg Lower doses may provide sufficient results Balance efficacy with tolerability Maintenance may involve dose reduction For general peptide dosing principles, see our peptide dosage calculator guide
Research consistently links elevated SHBG with greater risk of low muscle mass, especially in men
Wang Y, Astafiev SV, Fellah S, Guilliams KP, Fields ME, Mirro A et al (2024) Abstract TMP7: disruption of blood brain barrier is associated with silent cerebral infarcts in patients with sickle cell disease
The GIP pathway contributes to insulin sensitization through a distinct intracellular signaling cascade and may enhance fat cell lipolysis directly
Symptoms including right upper abdominal pain, nausea after fatty meals, and pain radiating to the right shoulder should be evaluated promptly
The preferred injection sites are in the thigh, abdomen , or upper arm
US$ 29.17
US$ 25.41
US$ 27.13
